These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24656850)

  • 1. Diagnostic accuracy and practice effects in the National Alzheimer's Coordinating Center Uniform Data Set neuropsychological battery.
    Mathews M; Abner E; Kryscio R; Jicha G; Cooper G; Smith C; Caban-Holt A; Schmitt FA
    Alzheimers Dement; 2014 Nov; 10(6):675-83. PubMed ID: 24656850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.
    Weintraub S; Salmon D; Mercaldo N; Ferris S; Graff-Radford NR; Chui H; Cummings J; DeCarli C; Foster NL; Galasko D; Peskind E; Dietrich W; Beekly DL; Kukull WA; Morris JC
    Alzheimer Dis Assoc Disord; 2009; 23(2):91-101. PubMed ID: 19474567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS).
    Weintraub S; Besser L; Dodge HH; Teylan M; Ferris S; Goldstein FC; Giordani B; Kramer J; Loewenstein D; Marson D; Mungas D; Salmon D; Welsh-Bohmer K; Zhou XH; Shirk SD; Atri A; Kukull WA; Phelps C; Morris JC
    Alzheimer Dis Assoc Disord; 2018; 32(1):10-17. PubMed ID: 29240561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia.
    Graves LV; Edmonds EC; Thomas KR; Weigand AJ; Cooper S; Bondi MW
    J Alzheimers Dis; 2020; 78(1):371-386. PubMed ID: 32986674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective.
    Nikolai T; Stepankova H; Kopecek M; Sulc Z; Vyhnalek M; Bezdicek O
    J Alzheimers Dis; 2018; 61(3):1233-1240. PubMed ID: 29332045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
    Müller S; Herde L; Preische O; Zeller A; Heymann P; Robens S; Elbing U; Laske C
    Sci Rep; 2019 Mar; 9(1):3543. PubMed ID: 30837580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.
    Morris JC; Weintraub S; Chui HC; Cummings J; Decarli C; Ferris S; Foster NL; Galasko D; Graff-Radford N; Peskind ER; Beekly D; Ramos EM; Kukull WA
    Alzheimer Dis Assoc Disord; 2006; 20(4):210-6. PubMed ID: 17132964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using multivariate base rates of low scores to understand early cognitive declines on the uniform data set 3.0 Neuropsychological Battery.
    Kiselica AM; Webber TA; Benge JF
    Neuropsychology; 2020 Sep; 34(6):629-640. PubMed ID: 32338945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.
    Besser L; Kukull W; Knopman DS; Chui H; Galasko D; Weintraub S; Jicha G; Carlsson C; Burns J; Quinn J; Sweet RA; Rascovsky K; Teylan M; Beekly D; Thomas G; Bollenbeck M; Monsell S; Mock C; Zhou XH; Thomas N; Robichaud E; Dean M; Hubbard J; Jacka M; Schwabe-Fry K; Wu J; Phelps C; Morris JC;
    Alzheimer Dis Assoc Disord; 2018; 32(4):351-358. PubMed ID: 30376508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
    Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.
    Reed BR; Mungas DM; Kramer JH; Ellis W; Vinters HV; Zarow C; Jagust WJ; Chui HC
    Brain; 2007 Mar; 130(Pt 3):731-9. PubMed ID: 17267522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.
    Langbaum JB; Hendrix SB; Ayutyanont N; Chen K; Fleisher AS; Shah RC; Barnes LL; Bennett DA; Tariot PN; Reiman EM
    Alzheimers Dement; 2014 Nov; 10(6):666-74. PubMed ID: 24751827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of conventional versus robust norming on cognitive characterization and clinical classification of MCI and dementia.
    Kaser AN; Kaplan DM; Goette W; Kiselica AM
    J Neuropsychol; 2023 Mar; 17(1):108-124. PubMed ID: 36124357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.
    Vemuri P; Weigand SD; Przybelski SA; Knopman DS; Smith GE; Trojanowski JQ; Shaw LM; Decarli CS; Carmichael O; Bernstein MA; Aisen PS; Weiner M; Petersen RC; Jack CR;
    Brain; 2011 May; 134(Pt 5):1479-92. PubMed ID: 21478184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment.
    Dwolatzky T; Whitehead V; Doniger GM; Simon ES; Schweiger A; Jaffe D; Chertkow H
    J Mol Neurosci; 2004; 24(1):33-44. PubMed ID: 15314247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.